A recent pause in U.S. sales of Varipulse is hampering the company’s bid to catch up in one of the industry’s fastest-growing ...

Precision Medicine Is the Future Of Healthcare When it comes to applied hard sciences, a source of progress has been more precise measurements and tools. This is especially true in physics and ...

OpenAI compared the feature to a research analyst and said it is meant to do in “tens of minutes” what would typically take a person “many hours.” Deep Research is the second AI agent that ...

“sure puts [the] Blackwell transition in perspective,” according to Melius Research analyst Ben Reitzes.

Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...

They are important niches to the scientists who can now solve previously unsolvable problems, but they may not constitute ...

Rare Stock Picks series, we're highlighting January 2025 investment picks. Click here for the list of January 2025 Buy ...

H.C. Wainwright downgraded Pliant Therapeutics (PLRX) to Neutral from Buy without a price target after the company voluntarily paused ...

Frank Laukien; Chairman of the Board, President, Chief Executive Officer; Bruker Corp Gerald Herman; Chief Financial Officer, Executive Vice President; Bruker Corp Good day, and welcome to the Bruker ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.